Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data

Vaccine. 2021 May 21;39(22):3037-3049. doi: 10.1016/j.vaccine.2021.01.054. Epub 2021 Feb 25.

Abstract

This is a Brighton Collaboration Case Definition of the term "Multisystem Inflammatory Syndrome in Children and Adults (MIS-C/A)" to be utilized in the evaluation of adverse events following immunization. The case definition was developed by topic experts convened by the Coalition for Epidemic Preparedness Innovations (CEPI) in the context of active development of vaccines for SARS-CoV-2. The format of the Brighton Collaboration was followed, including an exhaustive review of the literature, to develop a consensus definition and defined levels of certainty. The document underwent peer review by the Brighton Collaboration Network and by selected expert external reviewers prior to submission. The comments of the reviewers were taken into consideration and edits incorporated into this final manuscript.

Keywords: Adults; Adverse event; Case definition; Children; Guidelines; Immunization; MIS-A; MIS-C; Multisystem inflammatory syndrome.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adult
  • COVID-19 Vaccines
  • COVID-19*
  • Child
  • Data Collection
  • Humans
  • Immunization / adverse effects
  • SARS-CoV-2
  • Systemic Inflammatory Response Syndrome

Substances

  • COVID-19 Vaccines

Supplementary concepts

  • pediatric multisystem inflammatory disease, COVID-19 related